Evans Blue Dye: A Revisit of Its Applications in Biomedicine.
Evaluation of cardiac arrhythmic risks using a rabbit model of left ventricular systolic dysfunction.
The first study on therapeutic efficacies of a vascular disrupting agent CA4P among primary hepatocellular carcinomas with a full spectrum of differentiation and vascularity: Correlation of MRI-microangiography-histopathology in rats.
Evaluation of Necrosis Avidity and Potential for Rapid Imaging of Necrotic Myocardium of Radioiodinated Hypocrellins.
First Evaluation of Radioiodinated Flavonoids as Necrosis-Avid Agents and Application in Early Assessment of Tumor Necrosis.
Pancreatic imaging: Current status of clinical practices and small animal studies.
Vascular disrupting agent in pancreatic and hepatic tumour allografts: observations of location-dependent efficacy by MRI, microangiography and histomorphology.
Micro-HCCs in rats with liver cirrhosis: paradoxical targeting effects with vascular disrupting agent CA4P.
Everolimus halts hepatic cystogenesis in a rodent model of polycystic-liver-disease.
Evaluation of Radioiodinated 1,4-Naphthoquinones as Necrosis Avid Agents for Rapid Myocardium Necrosis Imaging.
An Imaging and Histological Study on Intrahepatic Microvascular Passage of Contrast Materials in Rat Liver.
